首页> 外文OA文献 >A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

【2h】

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

机译：来自乳腺或抗阉割前列腺癌骨转移患者的4-与12周内骨靶向剂的随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Mark Clemons; Michael Ong; Carol Stober; Scott Ernst; Christopher Booth; Christina Canil; Mihaela Mates; Andrew Robinson; Phillip Blanchette; Anil Abraham Joy; John Hilton; Olexiy Aseyev; Gregory Pond; Ahwon Jeong; Brian Hutton; Sasha Mazzarello; Lisa Vandermeer; Igal Kushnir; Dean Fergusson;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer [J] . D. Southcott, A. Awan, K. Ghate, Current oncology . 2020,第4期

机译：使用转移乳腺癌或抗阉割前列腺癌骨转移患者使用骨靶向剂的实际更新
2. Efficacy and safety of 12-weekly versus 4-weekly zoledronic acid for prolonged treatment of patients with bone metastases from breast cancer (ZOOM): A phase 3, open-label, randomised, non-inferiority trial [J] . AmadoriD., AgliettaM., AlessiB., The lancet oncology . 2013,第7期

机译：唑来膦酸12周和4周每周一次唑来膦酸对乳腺癌骨转移患者的长期治疗（ZOOM）的有效性和安全性：一项3期，开放标签，随机，非劣效性试验
3. Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer [J] . Vignani Francesca, Bertaglia Valentina, Buttigliero Consuelo, Cancer Treatment Reviews . 2016,第Null期

机译：去势抵抗性前列腺癌患者的骨骼转移及抗癌和骨靶向药物的影响
4. Castration-Resistant Prostate Cancer: Novel Targets, Agents, and Trials [C] . Evan Y. Yu Genitourinary Cancers Symposium . 2012

机译：抗阉割前列腺癌：新型靶点，药剂和试验
5. Determination of novel metabolites of therapeutic agents used in the treatment of castration-resistant prostate cancer. [D] . Alyamani, Mohammad. 2017

机译：测定用于去势抵抗性前列腺癌的治疗剂的新代谢产物。
6. Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer [O] . Megan M. Tu, Mark Clemons, Carol Stober, 2021

机译：从乳腺癌和抗阉割前列腺癌骨转移患者中12次与4周内给予骨靶向剂的成本效率分析
7. Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer [O] . Megan M. Tu, Mark Clemons, Carol Stober, 2021

机译：从乳腺癌和抗阉割前列腺癌骨转移患者中12次与4周内给予骨靶向剂的成本效率分析

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

著录项

引文网络

相似文献

相关主题

期刊订阅